Choi, Seung Ah <br/><br/>
Histone deacetylase inhibitor panobinostat potentiates the anti-cancer effects of mesenchymal stem cell-based sTRAIL gene therapy against malignant glioma.  [electronic resource] 

 -  Cancer letters  02 2019 
 - 161-169 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2018.10.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipose Tissue--cytology<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Brain Neoplasms--drug therapy<br/>Cell Survival--drug effects<br/>Chemotherapy, Adjuvant<br/>Coculture Techniques<br/>Female<br/>Genetic Therapy--methods<br/>Glioma--drug therapy<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Humans<br/>Male<br/>Mesenchymal Stem Cell Transplantation<br/>Mesenchymal Stem Cells--metabolism<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Middle Aged<br/>Panobinostat--pharmacology<br/>Phenotype<br/>Signal Transduction<br/>TNF-Related Apoptosis-Inducing Ligand--genetics<br/>Tumor Burden--drug effects<br/>Tumor Cells, Cultured<br/>Tumor Necrosis Factor Decoy Receptors--metabolism<br/>Xenograft Model Antitumor Assays